(Q33379498)

26 July 2017

1 reference

title

Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura (English)

1 reference

26 July 2017

1 reference

Sergio Amadori

3

0 references

Roberto Stasi

series ordinal

1

object named as

Roberto Stasi

1 reference

26 July 2017

Maria L Evangelista

2

1 reference

26 July 2017

publication date

1 January 2008

1 reference

26 July 2017

number of pages

12

1 reference

inferred from page(s)

published in

Drugs

1 reference

26 July 2017

volume

68

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

901-912

1 reference

The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.

26 July 2017

cites work

1 reference

12 December 2020

The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production

1 reference

12 December 2020

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

1 reference

12 December 2020

Treatment of immune thrombocytopenic purpura in adults

1 reference

12 December 2020

Thrombopoietin: the primary regulator of platelet production

1 reference

12 December 2020

Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP

1 reference

12 December 2020

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional

1 reference

12 December 2020

Management of patients with refractory immune thrombocytopenic purpura

1 reference

12 December 2020

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura

1 reference

12 December 2020

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

1 reference

12 December 2020

Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice

1 reference

12 December 2020

Thrombocytopenia caused by the development of antibodies to thrombopoietin

1 reference

12 December 2020

The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production

1 reference

12 December 2020

AMG 531: an investigational thrombopoiesis-stimulating peptibody

1 reference

12 December 2020

Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization

1 reference

12 December 2020

Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy

1 reference

12 December 2020

Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia

1 reference

12 December 2020

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

1 reference

12 December 2020

AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist

1 reference

12 December 2020

Platelet survival and turnover: important factors in predicting response to splenectomy in immune thrombocytopenic purpura

1 reference

12 December 2020

Thrombopoietin: accumulating evidence for an important biological effect on the hematopoietic stem cell

1 reference

12 December 2020

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

1 reference

12 December 2020

Hematopoietic growth factor mimetics

1 reference

12 December 2020

Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.

1 reference

12 December 2020

Danazol, idiopathic thrombocytopenic purpura, and thrombopoietin

1 reference

12 December 2020

Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura

1 reference

12 December 2020

How I treat idiopathic thrombocytopenic purpura (ITP).

1 reference

12 December 2020

Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics

1 reference

12 December 2020

Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation

1 reference

12 December 2020

Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production

1 reference

12 December 2020

Drug evaluation: AMG-531 for the treatment of thrombocytopenias

1 reference

12 December 2020

FcRn: the neonatal Fc receptor comes of age.

1 reference

12 December 2020

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer

1 reference

12 December 2020

The diagnostic value of thrombopoietin level measurements in thrombocytopenia.

1 reference

12 December 2020

Thrombopoietin: a pan-hematopoietic cytokine

1 reference

12 December 2020

Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice.

1 reference

12 December 2020

c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia

1 reference

12 December 2020

An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura

1 reference

12 December 2020

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.

1 reference

12 December 2020

The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts

1 reference

12 December 2020

Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance

1 reference

12 December 2020

Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Mechanisms of response to treatment in autoimmune thrombocytopenic purpura

1 reference

12 December 2020

Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders

1 reference

12 December 2020

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

1 reference

12 December 2020

Circulating thrombopoietin level in chronic immune thrombocytopenic purpura

1 reference

12 December 2020

Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets

1 reference

12 December 2020

Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro

1 reference

12 December 2020

Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study

1 reference

12 December 2020

Thrombocytopenia in c-mpl-deficient mice

1 reference

12 December 2020

Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice

1 reference

12 December 2020

AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand

1 reference

12 December 2020

Management of immune thrombocytopenic purpura in adults

1 reference

12 December 2020

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology

1 reference

12 December 2020

cMpl ligand is a humoral regulator of megakaryocytopoiesis

1 reference

12 December 2020

10.2165/00003495-200868070-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1031699644

0 references

1 reference